{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:28:25Z","timestamp":1791404905082,"version":"4.3.3"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1097\/qco.0b013e328359f04a","type":"journal-article","created":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T07:58:03Z","timestamp":1349423883000},"page":"709-717","source":"Crossref","is-referenced-by-count":85,"title":["Are new anthelmintics needed to eliminate human helminthiases?"],"prefix":"10.1097","volume":"25","author":[{"given":"Timothy G.","family":"Geary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210205","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1172\/JCI34261","article-title":"Helminth infections: the great neglected tropical diseases.","volume":"118","author":"Hotez","year":"2008","journal-title":"J Clin Invest"},{"key":"R3-14-20210205","doi-asserted-by":"crossref","first-page":"e1582","DOI":"10.1371\/journal.pntd.0001582","article-title":"A research agenda for helminth diseases of humans: the problem of helminthiases.","volume":"6","author":"Lustigman","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"R5-14-20210205","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra064142","article-title":"Control of neglected diseases.","volume":"357","author":"Hotez","year":"2007","journal-title":"N Engl J Med"},{"key":"R9-14-20210205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1586\/14787210.7.1.37","article-title":"Prospects for the control of neglected tropical diseases by mass drug administration.","volume":"7","author":"Smits","year":"2009","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"R10-14-20210205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4269\/ajtmh.2011.10-0411","article-title":"Integrated implementation of programs targeting neglected tropical diseases through preventive chemotherapy: proving the feasibility at national scale.","volume":"84","author":"Linehan","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"R11-14-20210205","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.trstmh.2011.08.013","article-title":"Preventive chemotherapy in human helminthiases: theoretical and operational aspects.","volume":"105","author":"Gabrielli","year":"2011","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R12-14-20210205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/B978-0-12-391429-3.00008-3","article-title":"Assessment and monitoring of onchocerciasis in Latin America.","volume":"77","author":"Rodriguez-Perez","year":"2011","journal-title":"Adv Parasitol"},{"key":"R13-14-20210205","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1756-3305-4-205","article-title":"Onchocerciasis in the Americas: from arrival to (near) elimination.","volume":"4","author":"Gustavsen","year":"2011","journal-title":"Parasit Vect"},{"key":"R14-14-20210205","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.actatropica.2010.08.009","article-title":"Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan) monotherapy.","volume":"120S","author":"Cupp","year":"2011","journal-title":"Acta Trop"},{"key":"R15-14-20210205","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/0974-777X.81692","article-title":"River blindness: an old disease on the brink of elimination and control.","volume":"3","author":"Winthrop","year":"2011","journal-title":"J Infect Glob Dis"},{"key":"R16-14-20210205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpara.2009.11.001","article-title":"Unresolved issues in anthelmintic pharmacology for helminthiases of humans.","volume":"40","author":"Geary","year":"2010","journal-title":"Int J Parasitol"},{"key":"R17-14-20210205","doi-asserted-by":"crossref","first-page":"e1549","DOI":"10.1371\/journal.pntd.0001549","article-title":"A research agenda for helminth diseases of humans: intervention for control and elimination.","volume":"6","author":"Prichard","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"R18-14-20210205","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1371\/journal.pntd.0000497","article-title":"Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.","volume":"3","author":"Diawara","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"R19-14-20210205","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1756-3305-5-28","article-title":"Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.","volume":"5","author":"Tekle","year":"2012","journal-title":"Parasit Vect"},{"key":"R20-14-20210205","first-page":"384","article-title":"Can ivermectin mass treatments eliminate onchocerciasis in Africa Bull World Health O","volume":"80","author":"Winnen","year":"2002","journal-title":"rg"},{"key":"R21-14-20210205","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1017\/S0031182008000425","article-title":"Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments.","volume":"135","author":"Bottomley","year":"2008","journal-title":"Parasitol"},{"key":"R22-14-20210205","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ijpara.2010.12.009","article-title":"Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination.","volume":"41","author":"Duerr","year":"2011","journal-title":"Int J Parasitol"},{"key":"R23-14-20210205","first-page":"16","article-title":"Elimination of onchocerciasis from Africa: possible Trends P","volume":"28","author":"Mackenzie","year":"2012","journal-title":"arasitol"},{"key":"R24-14-20210205","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0065-308X(05)61009-3","article-title":"Control of onchocerciasis.","volume":"61","author":"Boatin","year":"2006","journal-title":"Adv Parasitol"},{"key":"R25-14-20210205","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1179\/136485906X112202","article-title":"Toward the elimination of onchocerciasis.","volume":"100","author":"Thylefors","year":"2006","journal-title":"Ann Trop Med Parasitol"},{"key":"R26-14-20210205","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-3156.2010.02501.x","article-title":"Does onchocerciasis transmission take place in hypoendemic areas A study from the North Region of Cameroon.","volume":"15","author":"Katabarwa","year":"2010","journal-title":"Trop Med Int Health"},{"key":"R27-14-20210205","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.vetpar.2011.11.048","article-title":"An inconvenient truth: global worming and anthelmintic resistance.","volume":"186","author":"Kaplan","year":"2012","journal-title":"Vet Parasitol"},{"key":"R28-14-20210205","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1371\/journal.pntd.0000072","article-title":"Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment.","volume":"1","author":"Bourguinat","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"key":"R29-14-20210205","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0140-6736(07)60942-8","article-title":"Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study.","volume":"369","author":"Osei-Atweneboana","year":"2007","journal-title":"Lancet"},{"key":"R30-14-20210205","doi-asserted-by":"crossref","first-page":"e998","DOI":"10.1371\/journal.pntd.0000998","article-title":"Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus.","volume":"5","author":"Osei-Atweneboana","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"R31-14-20210205","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.vetpar.2011.01.023","article-title":"Genetic polymorphism in Dirofilaria immitis.","volume":"176","author":"Bourguinat","year":"2011","journal-title":"Vet Parasitol"},{"key":"R32-14-20210205","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.tcam.2011.09.004","article-title":"Evidence for macrocyclic lactone anthelmintic resistance in Dirofilaria immitis.","volume":"26","author":"Geary","year":"2011","journal-title":"Top Comp Anim Med"},{"key":"R33-14-20210205","doi-asserted-by":"crossref","first-page":"16716","DOI":"10.1073\/pnas.0906176106","article-title":"Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.","volume":"106","author":"Churcher","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R34-14-20210205","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/QCO.0b013e328315cde7","article-title":"Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis.","volume":"21","author":"Hoerauf","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"R35-14-20210205","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00430-007-0062-1","article-title":"Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study.","volume":"197","author":"Hoerauf","year":"2008","journal-title":"Med Microbiol Immunol"},{"key":"R36-14-20210205","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00436-008-1217-8","article-title":"Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus.","volume":"104","author":"Hoerauf","year":"2009","journal-title":"Parasitol Res"},{"key":"R37-14-20210205","doi-asserted-by":"crossref","first-page":"e660","DOI":"10.1371\/journal.pntd.0000660","article-title":"Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.","volume":"4","author":"Turner","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"R38-14-20210205","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/CMR.00057-10","article-title":"Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment.","volume":"24","author":"Tamarozzi","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"R39-14-20210205","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1756-3305-5-53","article-title":"Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis.","volume":"5","author":"Tamarozzi","year":"2012","journal-title":"Parasit Vect"},{"key":"R40-14-20210205","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1586\/eri.11.76","article-title":"Progress and challenges in the discovery of macrofilaricidal drugs.","volume":"9","author":"Geary","year":"2011","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"R41-14-20210205","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2174\/138920112800399077","article-title":"Macrocyclic lactone anthelmintics: spectrum of activity and mechanism of action.","volume":"13","author":"Geary","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"R42-14-20210205","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1586\/eri.11.30","article-title":"Flubendazole, a potentially valuable macrofilariacide for lymphatic filariasis and onchocerciasis field programs.","volume":"9","author":"Mackenzie","year":"2011","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"R43-14-20210205","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1756-3305-3-100","article-title":"The 6th Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: a half-time review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseases.","volume":"3","author":"Addiss","year":"2010","journal-title":"Parasit Vect"},{"key":"R44-14-20210205","first-page":"617","article-title":"Elimination of lymphatic filariasis: do we have the drugs to complete the job Curr Opin Infect D","volume":"23","author":"Bockarie","year":"2010","journal-title":"is"},{"key":"R45-14-20210205","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1469-0691.2011.03586.x","article-title":"Filariasis in Africa: treatment challenges and prospects.","volume":"17","author":"Hoerauf","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"R46-14-20210205","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0140-6736(05)66591-9","article-title":"Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial.","volume":"365","author":"Taylor","year":"2005","journal-title":"Lancet"},{"key":"R47-14-20210205","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/cid\/cis486","article-title":"Doxycycline improves filarial lymphedema independent of active filarial infection: a randomized controlled trial.","volume":"55","author":"Mand","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R48-14-20210205","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.2009.09-0155","article-title":"Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine.","volume":"81","author":"Mand","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"R49-14-20210205","doi-asserted-by":"crossref","first-page":"201617","DOI":"10.1155\/2011\/201617","article-title":"Macrofilaricidal activity in Wuchereria bancrofti after 2 weeks treatment with a combination of rifampicin plus doxycycline.","volume":"2011","author":"Debrah","year":"2011","journal-title":"J Parasitol Res"},{"key":"R50-14-20210205","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1086\/657063","article-title":"Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels.","volume":"51","author":"Dembele","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R51-14-20210205","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1056\/NEJMp0808041","article-title":"Toward the elimination of schistosomiasis.","volume":"360","author":"King","year":"2009","journal-title":"N Engl J Med"},{"key":"R53-14-20210205","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.qco.0000247591.13671.6a","article-title":"Schistosomiasis: challenges for control, treatment and drug resistance.","volume":"19","author":"Fenwick","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"R54-14-20210205","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1017\/S0021932007002301","article-title":"Resisting control of neglected tropical diseases: dilemmas in the mass treatment of schistosomiasis and soil-transmitted helminths in north-west Uganda.","volume":"40","author":"Parker","year":"2008","journal-title":"J Biosoc Sci"},{"key":"R55-14-20210205","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1017\/S0031182009990709","article-title":"Process evaluation of schistosomiasis control in Uganda, 2003-2006: perceptions, attitudes and constraints of a national programme.","volume":"136","author":"Fleming","year":"2009","journal-title":"Parasitol"},{"key":"R56-14-20210205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1478-4505-9-3","article-title":"Does mass drug administration for the integrated treatment of neglected tropical diseases really work Assessing evidence for the control of schistosomiasis and soil-transmitted helminths in Uganda.","volume":"9","author":"Parker","year":"2011","journal-title":"Health Res Policy Syst"},{"key":"R58-14-20210205","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1017\/S0031182009000493","article-title":"Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs.","volume":"136","author":"Doenhoff","year":"2009","journal-title":"Parasitol"},{"key":"R60-14-20210205","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1371\/journal.pntd.0000357","article-title":"Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment.","volume":"3","author":"Meyer","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"R61-14-20210205","doi-asserted-by":"crossref","first-page":"e1260","DOI":"10.1371\/journal.pntd.0001260","article-title":"Resolution of praziquantel.","volume":"5","author":"Woelfle","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"R62-14-20210205","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1017\/S0031182011000023","article-title":"Antiparasitic drugs for paediatrics: systematic review, formulations, pharmacokinetics, safety, efficacy and implications for control.","volume":"24","author":"Keiser","year":"2011","journal-title":"Parasitol"},{"key":"R63-14-20210205","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1017\/S0031182012000029","article-title":"Schistosomiasis in infants and preschool-aged children in sub-Saharan Africa: implication for control.","volume":"139","author":"Ekpo","year":"2012","journal-title":"Parasitol"},{"key":"R64-14-20210205","first-page":"3531","article-title":"Antimalarials in the treatment of schistosomiasis.","volume":"18","author":"Keiser","year":"2012","journal-title":"Curr Pharm Des"},{"key":"R65-14-20210205","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1001\/jama.299.16.1937","article-title":"Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis.","volume":"299","author":"Keiser","year":"2008","journal-title":"JAMA"},{"key":"R66-14-20210205","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0065-308X(10)73008-6","article-title":"The drugs we have and the drugs we need against major helminth infections.","volume":"73","author":"Keiser","year":"2010","journal-title":"Adv Parasitol"},{"key":"R67-14-20210205","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1371\/journal.pntd.0000397","article-title":"Assays to detect beta-tubulin codon 200 polymorphism in Trichuris trichiura and Ascaris lumbricoides.","volume":"3","author":"Diawara","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"R68-14-20210205","doi-asserted-by":"crossref","first-page":"e1417","DOI":"10.1371\/journal.pntd.0001417","article-title":"Low efficacy of single-dose albendazole and mebendazole against hookworm and effect on concomitant helminth infection in Lao PDR.","volume":"6","author":"Soukhathammavong","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"R69-14-20210205","doi-asserted-by":"crossref","first-page":"e948","DOI":"10.1371\/journal.pntd.0000948","article-title":"Assessment of the anthelmintic efficacy of albendazole in school children in seven countries where soil-transmitted helminths are endemic.","volume":"5","author":"Vercruysse","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"R71-14-20210205","doi-asserted-by":"crossref","first-page":"e11382011","DOI":"10.1371\/journal.pntd.0001138","article-title":"Potential drug development candidates for human soil-transmitted helminthiases.","volume":"5","author":"Olliaro","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl","key":"R72-14-20210205","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1007\/s00436-009-1492-z","article-title":"Field evaluation of the efficacy and safety of emodepside plus praziquantel tablets (Profender tablets for dogs) against naturally acquired nematode and cestode infections in dogs.","volume":"105","author":"Altreuther","year":"2009","journal-title":"Parasitol Res"},{"key":"R73-14-20210205","doi-asserted-by":"crossref","first-page":"e1547","DOI":"10.1371\/journal.pntd.0001547","article-title":"A research agenda for helminth diseases of humans: towards control and elimination.","volume":"6","author":"Boatin","year":"2012","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Current Opinion in Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QCO.0b013e328359f04a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:19:52Z","timestamp":1620973192000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001432-201212000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qco.0b013e328359f04a","relation":{},"ISSN":["0951-7375"],"issn-type":[{"value":"0951-7375","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}